Disclosure Of Entity's Operating Segments [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183077

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of entity's operating segments [text block]
Description of segments
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
66,997,000 EUR
22,668,000 EUR
Tax expense (income)
48,139,000 EUR
6,895,000 EUR
Profit (loss) before tax
11,480,000 EUR
123,769,000 EUR
Profit (loss)
59,620,000 EUR
59,620,000 EUR
116,875,000 EUR
116,875,000 EUR
Assets
442,414,000 EUR
421,918,000 EUR
Cash flows from (used in) operating activities
56,819,000 EUR
76,788,000 EUR
Cash flows from (used in) investing activities
25,490,000 EUR
54,682,000 EUR
Cash flows from (used in) financing activities
77,869,000 EUR
25,646,000 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.